June 2023 - Volume 12 - Issue 2 - Contributor Index

Alphabetical Search
C
E
F
I
J
L
M
N
O
Q
T
U
V
W
X
Y
Z
Author:
Al-Bast, Basma

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Author:
Hegde, Shruti

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Author:
Kropp, Robert

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Author:
Patel, Raj

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Author:
Roberts, Sarah
Author:
Saboo, Anuj
Author:
Sagalov, Andrew

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Author:
Salih, Mohsin

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.

Author:
Siddique, Momin

Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis

Deshpande, Radhika; Patel, Raj; Regmi, Manjari R.; More

Cardiovascular Endocrinology & Metabolism. 12(2):e0284, June 2023.